Protein Signature May Predict Who Responds to Hepatitis C Treatment
Friday, October 31, 2008 - 13:35
in Health & Medicine
(PhysOrg.com) -- A tell-tale set of newly-identified proteins may be able to predict who will most likely respond to standard therapy for hepatitis C infection, say researchers in the Duke Clinical Research Institute (DCRI). It is a development that could help patients facing one of the most taxing therapeutic regimens in medicine.